What is the normal range for serum potassium?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Normal Serum Potassium Levels

The traditional laboratory reference range for serum potassium is 3.5-5.5 mmol/L, but emerging evidence strongly suggests that optimal potassium levels for minimizing mortality and adverse outcomes are narrower, approximately 4.0-5.0 mmol/L, with the safest range appearing to be 4.2-5.0 mmol/L, particularly in patients with cardiovascular disease, heart failure, or chronic kidney disease 1.

Laboratory vs. Optimal Clinical Ranges

Standard Laboratory Reference Range

  • Traditional range: 3.5-5.5 mmol/L (or mEq/L) 2
  • Hypokalemia defined as: <3.5 mmol/L
    • Mild: 3.0-3.4 mmol/L
    • Moderate: 2.5-2.9 mmol/L
    • Severe: <2.5 mmol/L 2
  • Hyperkalemia defined as: >5.5 mmol/L
    • Mild: 5.5-6.4 mmol/L
    • Moderate: 6.5-8.0 mmol/L
    • Severe: >8.0 mmol/L 2

Optimal Range Based on Mortality Outcomes

The most recent and highest-quality evidence demonstrates that outcomes are best when potassium is maintained between 4.2-5.0 mmol/L 1. This 2026 individual patient data meta-analysis of 46,069 patients from 12 randomized controlled trials showed:

  • Lowest mortality risk: 4.2-5.0 mmol/L range
  • Reverse J-shaped association in heart failure with reduced ejection fraction (HFrEF)
  • U-shaped but flatter association in heart failure with preserved ejection fraction (HFpEF)
  • Even "mild hyperkalemia" (5.0-5.5 mmol/L) was not associated with worse outcomes in HFrEF 1

Context-Dependent Optimal Ranges

For Patients with Heart Failure, CKD, or Diabetes

Target potassium ≤5.0 mmol/L 3. Multiple observational studies demonstrate:

  • Potassium >5.0 mmol/L associated with increased mortality in these populations
  • Even high-normal levels (4.8-5.0 mmol/L) linked to higher 90-day mortality risk 3
  • Optimal range: 3.5-4.5 mmol/L in some cohorts 3
  • More specific ranges from various studies:
    • 3.9-4.5 mmol/L (post-MI patients on loop diuretics) 3
    • 4.1-4.7 mmol/L (hypertensive patients) 3

For Hospitalized Patients at Discharge

Discharge potassium of 4.0-4.4 mmol/L associated with lowest one-year mortality 4. A U-shaped association was observed with:

  • Increased mortality when discharge potassium ≤3.9 mmol/L
  • Increased mortality when discharge potassium ≥4.5 mmol/L
  • This was independent of admission potassium levels 4

For Critically Ill Patients on CRRT

Target range 3.0-4.0 mmol/L 5. A J-shaped association showed:

  • Lowest mortality with mean potassium 3.0-4.0 mmol/L
  • Higher potassium variability independently associated with increased mortality
  • Progressively increased mortality with increasing potassium variability 5

For Chronic Heart Failure Patients

High-normal potassium (5.0-5.5 mmol/L) may be beneficial 6. This contrasts with acute settings:

  • 68% of stable HF patients had potassium 4.0-5.0 mmol/L
  • High-normal levels (5.0-5.5 mmol/L) associated with improved survival (HR 0.78,95% CI 0.64-0.95)
  • Hypokalemia (≤3.5 mmol/L) associated with worst outcomes 6

Critical Clinical Caveats

Specimen Type Matters

Serum and plasma potassium differ by 0.2-0.4 mmol/L, with serum typically higher 7. Most laboratories incorrectly use the same reference interval for both:

  • Most clinical guidelines based on serum measurements
  • Plasma commonly used in acute care settings
  • Applying serum reference intervals to plasma results markedly affects interpretation 7

ECG Changes Are Unreliable

  • ECG changes typically don't manifest until potassium >6.5 mmol/L 2
  • Electrocardiographic manifestations vary among individuals and are not predictable 2
  • Other factors (pH, calcium, rate of change) influence complications independent of absolute potassium level 3

Practical Management Algorithm

For patients WITHOUT heart failure, CKD, or diabetes:

  • Maintain potassium 3.5-5.5 mmol/L (traditional range acceptable)
  • Optimal target: 4.0-5.0 mmol/L

For patients WITH heart failure, CKD, or diabetes:

  • Strict target: ≤5.0 mmol/L 3
  • Ideal range: 4.2-5.0 mmol/L 1
  • Avoid both hypokalemia (<3.5 mmol/L) and levels >5.0 mmol/L
  • Consider potassium binders if recurrent hyperkalemia >5.0 mmol/L 8

For hospitalized patients:

  • Target discharge potassium 4.0-4.4 mmol/L 4
  • Avoid discharge with potassium ≤3.9 or ≥4.5 mmol/L

For patients on RAASi therapy:

  • Do not discontinue RAASi for potassium 5.0-5.5 mmol/L 3, 9
  • Initiate potassium binders rather than stopping life-saving therapy 8, 9
  • Only discontinue RAASi if potassium >6.0-6.5 mmol/L 3, 9

Key Pitfall to Avoid

The most dangerous error is discontinuing RAASi therapy for mild hyperkalemia (5.0-5.5 mmol/L) 3, 8. This practice is associated with increased mortality, heart failure hospitalizations, and progression to end-stage kidney disease. Instead, use potassium binders (patiromer or sodium zirconium cyclosilicate) to maintain RAASi therapy 8, 9.

References

9
Guideline

clinical management of hyperkalemia.

Mayo Clinic Proceedings, 2021

Related Questions

What is the maximum amount of potassium (K) in milliequivalents that can be administered via a peripheral IV line at one time?
What complications can result from a slow intravenous infusion of potassium?
Can a serum potassium level of 3.3 mmol/L cause frequent urination in a patient using intermittent catheterization?
Is it safe to take an over-the-counter potassium supplement of 90 mg every day?
Is a serum potassium level of 3.9 mEq/L considered within the normal healthy range?
In a 25-year-old male with a previously normal ECG and no prior cardiac history, what is the appropriate work‑up when he develops intermittent palpitations or dyspnea?
By how many mEq/L does a 20 mEq dose of potassium chloride increase serum potassium in an adult with normal renal function?
In a 47-year-old female with a one-week history of right upper quadrant pain that worsens with bending or standing and improves when lying flat or standing still, and no associated symptoms, what is the most likely diagnosis and what initial work‑up and management should be pursued?
What does a reactive hepatitis A total antibody result and a quantitative hepatitis B surface antibody level mean?
In a heart‑failure patient with an eGFR of 50 mL/min/1.73 m² who is intolerant to carvedilol, what alternative beta‑blocker regimen and other guideline‑directed therapies should be used?
Is a partial pressure of arterial oxygen (PaO₂) of 66 mm Hg normal for a patient with chronic obstructive pulmonary disease (COPD), and what is the target PaO₂ range on arterial blood gas?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.